Mainz Biomed B.V. ( MYNZ) - Key Metrics
Stock symbol MYNZ is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker MYNZ was renamed to
QUCY
effective 2026-03-12.
MYNZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | ? | ? | ? | ? |
| 2024Q2 | $0.93 | -$19.73 | -$14.58 | -$14.79 |
| 2023Q4 | $0.49 | -$11.73 | -$10.53 | -$11.12 |
| 2023Q3 | $0.01 | -$0.39 | -$0.41 | -$0.41 |
| 2023Q2 | $0.02 | -$0.45 | -$0.17 | -$0.18 |
MYNZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | ? |
| 2024Q2 | ? | -0.17 |
| 2023Q4 | ? | -0.99 |
| 2023Q3 | ? | -1.85 |
| 2023Q2 | ? | -105.83 |
MYNZ
Price: $0.84
52 week price:
Earnings Per Share: -5.28 USD
P/E Ratio: -0.15
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: Germany
Volume: 15400
Market Capitalization: 3.3 million